Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04009967
Title Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning (PICT-01)
Acronym PICT-01
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors CHU de Quebec-Universite Laval
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
CHU de Québec-Université Laval Québec Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field